![Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E](https://pubs.rsc.org/image/article/2020/NJ/c9nj06202e/c9nj06202e-f1_hi-res.gif)
Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E
![PDF) Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis | Eleonora Cocco - Academia.edu PDF) Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis | Eleonora Cocco - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/73260542/mini_magick20211020-28066-1mffmro.png?1634799542)
PDF) Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis | Eleonora Cocco - Academia.edu
Bilateral cerebellar ataxia as the sole manifestation of a unilateral rostral pontine tegmental infarct Identification of amoeba
![Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E](https://pubs.rsc.org/image/article/2020/NJ/c9nj06202e/c9nj06202e-f2_hi-res.gif)
Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E
1 Change in disability in patients with multiple sclerosis: A 20 year prospective population based analysis Authors Dr Claire Hi
Cerebrospinal Fluid Complement System Biomarkers in Demyelinating Disease. Wioleta M. Zelek1, Dina Fathalla1, Angharad Morgan1,
Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis
![Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort - MD Willis, KE Harding, TP Pickersgill, M Wardle, OR Pearson, NJ Scolding, J Smee, NP Robertson, 2016 Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort - MD Willis, KE Harding, TP Pickersgill, M Wardle, OR Pearson, NJ Scolding, J Smee, NP Robertson, 2016](https://journals.sagepub.com/cms/10.1177/1352458515614092/asset/images/large/10.1177_1352458515614092-fig1.jpeg)